Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil.

Agnieszka Koper Sławomir Wileński Paulina Śledzińska Marek G Bebyn Krzysztof Koper

Published in: Journal of cancer research and clinical oncology (2023)

We have developed a prognostic model for refractory mCRC treated with Trifluridine/Tipiracil based on five variables. Moreover, we reported a nomogram which could be used by oncologists in clinic visits on a daily basis.

Keyphrases

metastatic colorectal cancer
prognostic factors
primary care
physical activity
lymph node metastasis
squamous cell carcinoma